Sativan, a natural product isolated and purified from the herbs of Trifolium pratense L., exhibits antituberculosis activity against Mycobacterium tuberculosis H37Rv, with the MIC value of 50 ug/mL, and can markedly reduce the expressions of matrix metalloproteinase-1 caused by ultraviolet irradiated cultured primary human skin fibroblasts.